Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) EBITDA (2025 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted EBITDA of -$51.51 million for Q2 2026, compared with -$4.8 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EBITDA (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at Lb Pharmaceuticals was -$78.75 million; for FY2025, it came in at -$24.88 million.

  • In prior years, Lb Pharmaceuticals' EBITDA was -$63.01 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 8.16 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.05 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - -62.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -62.37 Mn
Jun 30, 2026 -53.82 Mn
Mar 31, 2026 -22.02 Mn
Sep 30, 2025 -5.17 Mn
Jun 30, 2025 -4.78 Mn
Mar 31, 2025 -6.35 Mn
API Access

Lb Pharmaceuticals EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=LBRX&period=max&api_key=YOUR_API_KEY